These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 28603047
1. Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro. Yamamura A, Fujitomi E, Ohara N, Tsukamoto K, Sato M, Yamamura H. Eur J Pharmacol; 2017 Sep 05; 810():44-50. PubMed ID: 28603047 [Abstract] [Full Text] [Related]
2. Calcilytics enhance sildenafil-induced antiproliferation in idiopathic pulmonary arterial hypertension. Yamamura A, Yagi S, Ohara N, Tsukamoto K. Eur J Pharmacol; 2016 Aug 05; 784():15-21. PubMed ID: 27164419 [Abstract] [Full Text] [Related]
3. Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension. Yamamura A, Ohara N, Tsukamoto K. PLoS One; 2015 Aug 05; 10(9):e0138384. PubMed ID: 26375676 [Abstract] [Full Text] [Related]
4. Capsaicin-induced Ca2+ signaling is enhanced via upregulated TRPV1 channels in pulmonary artery smooth muscle cells from patients with idiopathic PAH. Song S, Ayon RJ, Yamamura A, Yamamura H, Dash S, Babicheva A, Tang H, Sun X, Cordery AG, Khalpey Z, Black SM, Desai AA, Rischard F, McDermott KM, Garcia JG, Makino A, Yuan JX. Am J Physiol Lung Cell Mol Physiol; 2017 Mar 01; 312(3):L309-L325. PubMed ID: 27979859 [Abstract] [Full Text] [Related]
5. Pro-apoptotic effects of imatinib on PDGF-stimulated pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Nakamura K, Akagi S, Ogawa A, Kusano KF, Matsubara H, Miura D, Fuke S, Nishii N, Nagase S, Kohno K, Morita H, Oto T, Yamanaka R, Otsuka F, Miura A, Yutani C, Ohe T, Ito H. Int J Cardiol; 2012 Aug 23; 159(2):100-6. PubMed ID: 21376411 [Abstract] [Full Text] [Related]
6. Upregulated ClC3 Channels/Transporters Elicit Swelling-Activated Cl- Currents and Induce Excessive Cell Proliferation in Idiopathic Pulmonary Arterial Hypertension. Amano T, Yamamura A, Fujiwara M, Hirai S, Kondo R, Suzuki Y, Yamamura H. Biol Pharm Bull; 2022 Nov 01; 45(11):1684-1691. PubMed ID: 35989293 [Abstract] [Full Text] [Related]
8. T-type Ca2+ channels elicit pro-proliferative and anti-apoptotic responses through impaired PP2A/Akt1 signaling in PASMCs from patients with pulmonary arterial hypertension. Sankhe S, Manousakidi S, Antigny F, Arthur Ataam J, Bentebbal S, Ruchon Y, Lecerf F, Sabourin J, Price L, Fadel E, Dorfmüller P, Eddahibi S, Humbert M, Perros F, Capuano V. Biochim Biophys Acta Mol Cell Res; 2017 Oct 01; 1864(10):1631-1641. PubMed ID: 28655554 [Abstract] [Full Text] [Related]
9. Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Akagi S, Nakamura K, Matsubara H, Kusano KF, Kataoka N, Oto T, Miyaji K, Miura A, Ogawa A, Yoshida M, Ueda-Ishibashi H, Yutani C, Ito H. Int J Cardiol; 2013 May 25; 165(3):499-505. PubMed ID: 21955608 [Abstract] [Full Text] [Related]
13. [Molecular Mechanism of Dihydropyridine Ca2+ Channel Blockers in Pulmonary Hypertension]. Yamamura A. Yakugaku Zasshi; 2016 May 25; 136(10):1373-1377. PubMed ID: 27725386 [Abstract] [Full Text] [Related]
14. Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous. Perros F, Sentenac P, Boulate D, Manaud G, Kotsimbos T, Lecerf F, Lamrani L, Fadel E, Mercier O, Londono-Vallejo A, Humbert M, Eddahibi S. Int J Mol Sci; 2019 Jul 22; 20(14):. PubMed ID: 31336611 [Abstract] [Full Text] [Related]
15. SKF96365 activates calcium-sensing receptors in pulmonary arterial smooth muscle cells. Miyaki R, Yamamura A, Kawade A, Fujiwara M, Kondo R, Suzuki Y, Yamamura H. Biochem Biophys Res Commun; 2022 Jun 04; 607():44-48. PubMed ID: 35366542 [Abstract] [Full Text] [Related]
16. Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension. Nakamura K, Sakaguchi M, Matsubara H, Akagi S, Sarashina T, Ejiri K, Akazawa K, Kondo M, Nakagawa K, Yoshida M, Miyoshi T, Ogo T, Oto T, Toyooka S, Higashimoto Y, Fukami K, Ito H. PLoS One; 2018 Jun 04; 13(9):e0203046. PubMed ID: 30180189 [Abstract] [Full Text] [Related]